Faculty profile

Scott Bratman

ResearcherRadiation OncologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Scott Bratman

Researcher

Radiation Oncology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
25 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2025.
Supervised 4 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Radiotherapy Ctdna Adaptive Therapy De-Escalation Head And Neck Cancer Hpv Personalized Medicine Surgery

Latest papers

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.
Head & neck · 2026
Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.
Oral oncology · 2026
Auto-segmentation of organs-of-interest clinical acceptability & reproducibility framework in head and neck cancer.
Physics and imaging in radiation oncology · 2026

All 32 publications

Latest funding

Liquid-biopsy profiling of EZH2-driven H3K27me3 remodeling to overcome treatment resistance in small-cell lung cancer
CIHR · 2026 · Co-investigator
$1,109,250
The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer
CIHR · 2025 · Nominated PI
$1,071,000
Epigenetic dynamics of small cell lung cancer during therapy
CIHR · 2025 · Supervisor
$120,000

All 15 grants and awards

32 publications.

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Chelvarajah RC, Chee LYS, Su J, O'Sullivan B, Yao CMKL, Sanz-Garcia E, Smith SM, Weinreb I, Bratman S, Cho BCJ, Hahn E, Hope A, Hosni A, Kim J, McPartlin A, Malik N, Tsai CJ, de Almeida J, Spreafico A, Tong L, Huang SH, Waldron JN

Head & neck2026

DOI: 10.1002/hed.70230 PMID: 41816946

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Ly S, Rühle A, Bratman S, Cho J, Hosni A, Hahn E, Kim J, McPartlin A, Ringash J, O'Sullivan B, Tsai CJ, Waldron J, Goldstein D, Sanz-Garcia E, Spreafico A, Su J, Tong L, Weinreb I, Huang SH, Hope A

Oral oncology2026

DOI: 10.1016/j.oraloncology.2026.108006 PMID: 42127862

Auto-segmentation of organs-of-interest clinical acceptability & reproducibility framework in head and neck cancer.

Marsilla J, Welch ML, Siraj J, McElcheran C, Kim JW, Tkachuck D, Kim S, Cho J, Hahn E, Hosni A, Jacinto JC, Kazmierski M, Rey-McIntyre K, Huang SH, Patel T, Tadic T, Bratman S, Hope A, Haibe-Kains B

Physics and imaging in radiation oncology2026

DOI: 10.1016/j.phro.2026.101015 PMID: 42376454

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Gaspar C, Wu B, Stone SC, Sotov V, Wang B, Wangulu C, Berman H, Kay A, Basra P, Van de Laar E, Bratman S, Lheureux S, Knox J, Kim R, He H, Liu G, Bedard P, Spreafico A, Tsao M, Pugh TJ, Hansen A, Sapisochin G, Garcia ES, Siu LL, Bruce JP

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1876853 PMID: 42625601

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Moharrami M, Watson E, Huang SH, Madathil S, Kim J, McPartlin A, Malik NH, Singhal S, Hahn E, Waldron J, Bratman S, de Almeida J, Yao C, Hope A, Quinonez C, Glogauer M, Hosni A

Journal of medical systems2026

DOI: 10.1007/s10916-026-02359-4 PMID: 41801474

Unilateral vs bilateral neck irradiation: The importance of careful patient selection in tailoring radiation therapy for lateralized palatine-tonsil and non-palatine-tonsil oropharyngeal carcinoma.

Gau M, Alfaraj FA, Huang SH, O'Sullivan B, Su J, Xu W, Hamilton SN, Maletta A, Salman O, McInerney M, Javed A, Sanz-Garcia E, Bratman S, Hahn E, Hope A, Kim JJ, Malik N, McPartlin A, Tsai CJ, Waldron J, Yao CMKL, de Almeida JR, Hosni A

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2025

DOI: 10.1016/j.radonc.2025.111049 PMID: 40692081

Defining the optimal radiation thresholds for Stratifying jaw osteoradionecrosis risk in head and neck cancer.

Moharrami M, Watson E, Huang SH, Madathil S, Kim J, McPartlin A, Malik NH, Singhal S, Tsai CJ, Waldron J, Bratman S, Hope A, de Almeida J, Yao CM, Goldstein D, Quinonez C, Glogauer M, Hosni A

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2025

DOI: 10.1016/j.radonc.2025.110996 PMID: 40544869

Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancer.

Yao CMKL, Hueniken K, Huang SH, Liu G, Bratman S, Hope A, McPartlin A, Tsai JC, Tzelnik S, Goldstein D, Hosni A, Chan TCY, de Almeida JR

Oral oncology2025

DOI: 10.1016/j.oraloncology.2025.107304 PMID: 40253900

Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.

Chelvarajah RC, Liu Y, Su J, Abdalaty AH, Bratman S, John Cho BC, Hahn E, Hope A, Kim J, O'Sullivan B, Ringash J, Jillian Tsai C, Waldron J, Spreafico A, Garcia ES, Goldstein D, Yao C, Tong L, Huang SH, McPartlin A

Oral oncology2025

DOI: 10.1016/j.oraloncology.2025.107310 PMID: 40250146

Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer.

Elliott MJ, Howarth K, Main S, Fuentes Antrás J, Echelard P, Dou A, Amir E, Nadler MB, Shah E, Yu C, Bratman S, Bird T, Roh J, de Bruin EC, Rushton C, Chen Y, Gladchuk S, George AM, Birkeälv S, Alcaide M, Oton L, Putcha G, Woodhouse S, Bedard PL, Siu LL, Berman HK, Cescon DW

Clinical cancer research : an official journal of the American Association for Cancer Research2025

DOI: 10.1158/1078-0432.ccr-24-3472 PMID: 39785866

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Radiotherapy Dear Professor Bratman, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Scott Bratman

Research

Latest papers

Latest funding

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Auto-segmentation of organs-of-interest clinical acceptability & reproducibility framework in head and neck cancer.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Unilateral vs bilateral neck irradiation: The importance of careful patient selection in tailoring radiation therapy for lateralized palatine-tonsil and non-palatine-tonsil oropharyngeal carcinoma.

Defining the optimal radiation thresholds for Stratifying jaw osteoradionecrosis risk in head and neck cancer.

Development of a patient reported outcomes based machine learning model to predict recurrences in head and neck cancer.

Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.

Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer.

Frequent collaborators

Andrew Hope

John Kim

Anna Spreafico

John de Almeida

Wei Xu

Meredith Giuliani

Benjamin Haibe-Kains

Christopher Yao

Ian Witterick

Lillian Siu

Enrique Sanz Garcia

Geoffrey Liu

Michael Glogauer

Jonathan Irish

Sonica Singhal

Sreenath Madathil

Carlos Quiñonez

Xuan Li

Stephanie Lheureux

Eitan Amir

Gonzalo Sapisochin

Lawson Eng

Philip Wong

Philippe Bedard

Patrick Veit-Haibach

Anand Swaminath

Rosemary Martino

Raymond Kim

Laurie Ailles